Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Fidelity China Special Situations Plc
If you like China, why invest via FCSS?
23rd Mar 2023
City of London Investment Group
Solid results in volatile markets
22nd Mar 2023
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
72: What happened at Silicon Valley Bank and its effect on UK venture capital | Brian Moretta of Hardman & Co
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Shield Therapeutics Plc
Life Sciences
Positioned for growth and profitability
By
Dr Martin Hall
13 Jan 2023
Volta Finance
Investment Companies
R&A shining light on 20%+ IRR base-case scenarios
By
Mark Thomas
11 Jan 2023
Stay up-to-date with the latest research
Sign up to our newsletter
The Monthly: January 2023
10 Jan 2023
Life Sciences
Hardman & Co Healthcare Index
By
Dr Martin Hall
06 Jan 2023
Fidelity China Special Situations Plc
Investment Companies
Government controls put into perspective
By
Mark Thomas
04 Jan 2023
The Fulham Shore
Consumer
Resilient first-half trading
By
Jason Streets
03 Jan 2023
Cornerstone
Technology
Pragmatic strategic reset under the new CEO
22 Dec 2022
Surface Transforms
Industrial
Major OEM 10 order, OEM 8 delay resolved
By
Mike Foster
15 Dec 2022
Fidelity Special Values Plc
Investment Companies
Questions for the 2022 AGM on 14 December
By
Dr Brian Moretta
12 Dec 2022
International Biotechnology Trust
Life Sciences
Low FDA activity may drive further M&A
By
Dr Martin Hall
08 Dec 2022
Oakley Capital Investments
Investment Companies
Evolution of the high-growth drivers in 2023
By
Mark Thomas
29 Nov 2022
Prev
1
2
3
4
5
...
67
Next
